SYCN
gene geneOn this page
Also known as SYLFLJ27441
Summary
SYCN (syncollin, HGNC:18442) is a protein-coding gene on chromosome 19q13.2, encoding Syncollin (Q0VAF6). Functions in exocytosis in pancreatic acinar cells regulating the fusion of zymogen granules with each other.
Predicted to be involved in exocytosis. Predicted to be located in zymogen granule membrane.
Source: NCBI Gene 342898 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 33 total
- MANE Select transcript:
NM_001080468
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18442 |
| Approved symbol | SYCN |
| Name | syncollin |
| Location | 19q13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SYL, FLJ27441 |
| Ensembl gene | ENSG00000179751 |
| Ensembl biotype | protein_coding |
| OMIM | 620140 |
| Entrez | 342898 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000318438
RefSeq mRNA: 1 — MANE Select: NM_001080468
NM_001080468
CCDS: CCDS46070
Canonical transcript exons
ENST00000318438 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001238865 | 39203860 | 39204263 |
| ENSE00001620914 | 39202825 | 39202996 |
Expression profiles
Bgee: expression breadth ubiquitous, 132 present calls, max score 99.87.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 29.0686 / max 39321.5342, expressed in 20 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 180844 | 29.0686 | 20 |
Top tissues by expression
251 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| body of pancreas | UBERON:0001150 | 99.87 | gold quality |
| pancreas | UBERON:0001264 | 94.21 | gold quality |
| right testis | UBERON:0004534 | 87.21 | gold quality |
| left testis | UBERON:0004533 | 86.87 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.71 | gold quality |
| islet of Langerhans | UBERON:0000006 | 84.00 | gold quality |
| testis | UBERON:0000473 | 83.73 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 81.59 | silver quality |
| lower esophagus mucosa | UBERON:0035834 | 66.24 | gold quality |
| right coronary artery | UBERON:0001625 | 65.75 | gold quality |
| ectocervix | UBERON:0012249 | 65.34 | gold quality |
| adult organism | UBERON:0007023 | 64.17 | silver quality |
| body of stomach | UBERON:0001161 | 64.04 | gold quality |
| fundus of stomach | UBERON:0001160 | 62.52 | gold quality |
| right lobe of liver | UBERON:0001114 | 62.22 | gold quality |
| left uterine tube | UBERON:0001303 | 61.58 | gold quality |
| right adrenal gland | UBERON:0001233 | 60.93 | gold quality |
| right uterine tube | UBERON:0001302 | 60.32 | gold quality |
| esophagus mucosa | UBERON:0002469 | 60.00 | gold quality |
| endocervix | UBERON:0000458 | 59.67 | gold quality |
| metanephros cortex | UBERON:0010533 | 59.18 | gold quality |
| oocyte | CL:0000023 | 58.21 | gold quality |
| duodenum | UBERON:0002114 | 58.20 | gold quality |
| amniotic fluid | UBERON:0000173 | 57.67 | gold quality |
| stomach | UBERON:0000945 | 57.64 | gold quality |
| left adrenal gland | UBERON:0001234 | 57.51 | gold quality |
| uterine cervix | UBERON:0000002 | 57.31 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 56.91 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 56.43 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 56.30 | gold quality |
Single-cell (SCXA)
Detected in 5 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-81547 | yes | 5472.40 |
| E-MTAB-5061 | yes | 18.83 |
| E-ENAD-27 | yes | 7.31 |
| E-GEOD-83139 | no | 2.57 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- Additional serum biomarkers, particularly SYCN and REG1B, when combined with CA19.9, show promise as improved diagnostic indicators of pancreatic cancer, which therefore warrants further validation. (PMID:24007603)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | sycn.1 | ENSDARG00000090469 |
| danio_rerio | sycn.3 | ENSDARG00000090899 |
| danio_rerio | sycn.2 | ENSDARG00000103687 |
| mus_musculus | Sycn | ENSMUSG00000084174 |
| rattus_norvegicus | Sycn | ENSRNOG00000019879 |
Protein
Protein identifiers
Syncollin — Q0VAF6 (reviewed: Q0VAF6)
Alternative names: Insulin synthesis-associated protein 1
All UniProt accessions (1): Q0VAF6
UniProt curated annotations — full annotation on UniProt →
Function. Functions in exocytosis in pancreatic acinar cells regulating the fusion of zymogen granules with each other. May have a pore-forming activity on membranes and regulate exocytosis in other exocrine tissues.
Subunit / interactions. Monomer and homooligomer; most probably hexameric. Interacts with GP2.
Subcellular location. Zymogen granule membrane. Zymogen granule lumen.
Post-translational modifications. Contains intrachain disulfide bonds.
RefSeq proteins (1): NP_001073937* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR028137 | Syncollin | Family |
Pfam: PF15138
UniProt features (3 total): signal peptide 1, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q0VAF6-F1 | 88.44 | 0.71 |
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-9925561 | Developmental Lineage of Pancreatic Acinar Cells |
| R-HSA-1266738 | Developmental Biology |
| R-HSA-9734767 | Developmental Cell Lineages |
MSigDB gene sets: 44 (showing top):
GOCC_SECRETORY_GRANULE, GOBP_VESICLE_MEDIATED_TRANSPORT, GOBP_EXOCYTOSIS, GOBP_SECRETION, GOCC_ZYMOGEN_GRANULE, GOCC_SECRETORY_VESICLE, GOCC_SECRETORY_GRANULE_MEMBRANE, RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP, YOSHIMURA_MAPK8_TARGETS_UP, FEVR_CTNNB1_TARGETS_UP, SERVITJA_ISLET_HNF1A_TARGETS_UP, GSE13522_WT_VS_IFNG_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN, GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_UP, HES2_TARGET_GENES, MEF2D_TARGET_GENES
GO Biological Process (1): exocytosis (GO:0006887)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (4): zymogen granule membrane (GO:0042589), membrane (GO:0016020), secretory granule membrane (GO:0030667), cytoplasmic vesicle (GO:0031410)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Developmental Cell Lineages of the Exocrine Pancreas | 1 |
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| vesicle-mediated transport | 1 |
| secretion by cell | 1 |
| vesicle fusion to plasma membrane | 1 |
| binding | 1 |
| secretory granule membrane | 1 |
| zymogen granule | 1 |
| cellular anatomical structure | 1 |
| secretory granule | 1 |
| cytoplasmic vesicle membrane | 1 |
| bounding membrane of organelle | 1 |
| cytoplasm | 1 |
| intracellular vesicle | 1 |
Protein interactions and networks
STRING
468 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SYCN | ZG16 | O60844 | 584 |
| SYCN | PNLIPRP1 | P54315 | 582 |
| SYCN | REG1B | P48304 | 564 |
| SYCN | RXFP4 | Q8TDU9 | 523 |
| SYCN | DTNA | Q9Y4J8 | 475 |
| SYCN | GP2 | P55259 | 472 |
| SYCN | CELA3B | P08861 | 468 |
| SYCN | CUZD1 | Q86UP6 | 455 |
| SYCN | CPA1 | P15085 | 440 |
| SYCN | FKRP | Q9H9S5 | 424 |
| SYCN | PIGR | P01833 | 413 |
| SYCN | CELA2A | P08217 | 413 |
| SYCN | PTPRN2 | Q92932 | 404 |
| SYCN | WDR86 | Q86TI4 | 381 |
| SYCN | CLPSL1 | A2RUU4 | 376 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SYCN | AIP | psi-mi:“MI:0914”(association) | 0.500 |
| SYCN | AIP | psi-mi:“MI:0915”(physical association) | 0.500 |
| SYCN | H2BC9 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (7): HIST1H2BH (Proximity Label-MS), AIP (Affinity Capture-MS), CNTNAP1 (Affinity Capture-MS), SULF1 (Affinity Capture-MS), HSPA5 (Affinity Capture-MS), COL14A1 (Affinity Capture-MS), BIRC2 (Affinity Capture-MS)
ESM2 similar proteins: A0A346CIA0, A0A346CIB0, A0A346CIB2, A0A346CIB3, A0A7S8RFI7, A0S864, A0S865, A6MFK5, A7E3W2, A7X3V0, A7X4Q3, A7X4R0, A8HDK4, A8HDK7, A8HDK8, A8HDK9, B2BRQ6, F8J2B3, F8J2D7, F8J2E1, F8J2E2, F8J2E5, G3V686, O12961, O35775, O43278, O70513, O75339, P01384, P07358, P14612, P26776, P35495, P55314, P59899, P60615, P60616, P80915, P83880, P98136
Diamond homologs: O35775, Q0VAF6, Q8VCK7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
33 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 30 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
163 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:39203970:G:A | donor_gain | 0.9000 |
| 19:39203736:C:CA | donor_gain | 0.8500 |
| 19:39203884:TTGG:T | donor_gain | 0.8000 |
| 19:39203918:C:CA | donor_gain | 0.7900 |
| 19:39203862:G:A | donor_gain | 0.7500 |
| 19:39202992:TGCAC:T | acceptor_loss | 0.7300 |
| 19:39202993:GCAC:G | acceptor_loss | 0.7300 |
| 19:39202994:CACCT:C | acceptor_loss | 0.7300 |
| 19:39202995:AC:A | acceptor_loss | 0.7300 |
| 19:39202996:CC:C | acceptor_loss | 0.7300 |
| 19:39202997:C:T | acceptor_loss | 0.7300 |
| 19:39202998:T:G | acceptor_loss | 0.7300 |
| 19:39203002:A:C | acceptor_loss | 0.7000 |
| 19:39202962:C:CC | acceptor_gain | 0.6900 |
| 19:39202999:G:C | acceptor_loss | 0.6900 |
| 19:39203000:AAA:A | acceptor_loss | 0.6800 |
| 19:39203004:G:C | acceptor_loss | 0.6800 |
| 19:39203001:AATG:A | acceptor_loss | 0.6400 |
| 19:39203854:GGGCA:G | donor_loss | 0.6400 |
| 19:39203855:GGCA:G | donor_loss | 0.6400 |
| 19:39203856:GCA:G | donor_loss | 0.6400 |
| 19:39203857:CA:C | donor_loss | 0.6400 |
| 19:39203858:A:C | donor_loss | 0.6400 |
| 19:39203859:C:CG | donor_loss | 0.6400 |
| 19:39203860:C:G | donor_loss | 0.6400 |
| 19:39203961:G:A | donor_gain | 0.6300 |
| 19:39202961:GCTGC:G | acceptor_gain | 0.6100 |
| 19:39203527:CAG:C | donor_gain | 0.5900 |
| 19:39203895:T:TA | donor_gain | 0.5900 |
| 19:39203861:T:C | donor_loss | 0.5700 |
AlphaMissense
837 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:39203947:A:C | F103C | 0.988 |
| 19:39203889:C:A | W122C | 0.986 |
| 19:39203889:C:G | W122C | 0.986 |
| 19:39203946:G:C | F103L | 0.986 |
| 19:39203946:G:T | F103L | 0.986 |
| 19:39203948:A:G | F103L | 0.986 |
| 19:39203982:C:A | W91C | 0.984 |
| 19:39203982:C:G | W91C | 0.984 |
| 19:39203947:A:G | F103S | 0.979 |
| 19:39204036:C:A | W73C | 0.974 |
| 19:39204036:C:G | W73C | 0.974 |
| 19:39203984:A:G | W91R | 0.965 |
| 19:39203984:A:T | W91R | 0.965 |
| 19:39203992:A:T | L88H | 0.963 |
| 19:39204016:A:T | L80H | 0.961 |
| 19:39203891:A:G | W122R | 0.958 |
| 19:39203891:A:T | W122R | 0.958 |
| 19:39203967:C:A | K96N | 0.955 |
| 19:39203967:C:G | K96N | 0.955 |
| 19:39203998:C:G | C86S | 0.947 |
| 19:39203999:A:T | C86S | 0.947 |
| 19:39204139:G:T | A39D | 0.941 |
| 19:39203862:G:C | C131W | 0.940 |
| 19:39204120:G:C | S45R | 0.940 |
| 19:39204120:G:T | S45R | 0.940 |
| 19:39204122:T:G | S45R | 0.940 |
| 19:39203863:C:T | C131Y | 0.931 |
| 19:39203998:C:T | C86Y | 0.931 |
| 19:39204097:C:G | C53S | 0.931 |
| 19:39204098:A:T | C53S | 0.931 |
dbSNP variants (sampled 300 via entrez): RS1000168233 (19:39205970 G>A), RS1000471317 (19:39206032 T>C,G), RS1001572415 (19:39203134 G>T), RS1003338282 (19:39203816 G>A,T), RS1003564331 (19:39205523 A>G), RS1004244928 (19:39203060 A>G), RS1005222105 (19:39204316 A>G), RS1005617886 (19:39205052 G>A,T), RS1006807960 (19:39202366 C>A,G), RS1007377982 (19:39205670 A>C), RS1008796462 (19:39204832 G>A), RS1009261750 (19:39204448 T>G), RS1009670897 (19:39202569 C>A,T), RS1010323822 (19:39203563 A>G), RS1010504184 (19:39204419 G>A)
Disease associations
OMIM: gene MIM:620140 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Oxygen | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.